Published 16:54 IST, May 8th 2024
Cipla receives Form 483 observation from USFDA for Maharashtra facility
The Form 483, issued by the US Food and Drug Administration (USFDA), signifies observations made by inspectors at the conclusion of an inspection.
Cipla's revenue from operations during Q3 reached Rs 6,603.81 crore. | Image:
Freepik
- Listen to this article
- 1 min read
Advertisement
16:54 IST, May 8th 2024